社区多格服药辅助器中潜在不适当用药的患病率
该研究评估苏格兰东北部社区多格服药辅助器(MCA)使用者中潜在不适当用药(PIM)的患病率。2014年6月至10月期间,记录48家社区药房配发的MCA及相关处方、人口学数据和社会剥夺指数。结果显示57.8%的患者存在PIM,43%的患者有至少一种临床显著药物相互作用,女性、年龄<80岁和较低社会经济地位与PIM风险增加相关。
要点
- 57.8%的社区MCA使用者存在至少一种PIM。
- 43%的患者处方中包含至少一种临床显著药物相互作用。
- 女性、年龄<80岁和较低社会经济地位与PIM风险增加相关。
核心结论
- 社区MCA使用者中PIM发生率显著,尤其影响80岁以下和社会经济剥夺地区人群。
- 研究提示需要对MCA使用者进行更积极的多学科药物审查。
研究设计与样本
- 回顾性横断面研究,收集2014年6月1日至10月31日苏格兰阿伯丁市48家社区药房配发的MCA数据。
- 应用瑞典国家卫生与福利委员会的药物特异性PIM质量指标,采用双变量逻辑回归分析人口学变量关联。
主要发现
- 共识别1977种PIM,影响57.8%的患者。
- 中位年龄82岁(范围12-105岁),女性占59%。
- 四分之一患者处方≥10种药物,43%患者有至少一种临床显著DDI,十类药物占所有DDI的76%。
- 女性与所有PIM指标风险增加相关;年龄<80岁与使用三种及以上精神药物相关(OR 5.88, 95%CI 2.96-11.70, P<0.001)。
- 较低社会经济地位与处方≥10种药物(OR 1.43, 95%CI 1.16-1.78)和长效苯二氮䓬类药物处方(OR 1.84, 95%CI 1.14-2.98)相关。
临床怎么用
- 对社区MCA使用者应进行多学科药物审查,重点关注PIM和DDI。
- 特别关注80岁以下和社会经济剥夺地区的MCA使用者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the prevalence of potentially inappropriate medications (PIMs) use in a population of community-based multicompartment compliance aid (MCA) users in north-east Scotland. METHODS: Data for MCAs dispensed by 48 of the 50 community pharmacies in Aberdeen City between 1st June to 31st October 2014, together with concurrently prescribed medications, patient demographics and Carstairs index of social deprivation were recorded. Drug-specific quality indicators for PIMs from the Swedish National Board of Health and Welfare were applied and bivariate logistic regression analysis used to assess for associations with demographic variables. RESULTS: The median age was 82 years (range 12-105 years, 59% female). A total of 1977 PIMs were identified affecting 57.8% of patients. A quarter of patients were prescribed ≥10 medications and 43% had a prescription containing at least one clinically significant drug-drug interaction (DDI). Ten drug groups accounted for 76% of all DDIs. A significant increase in the risk for at least one PIM was associated with female sex (for all indicators of PIM use), age <80 years (three or more psychotropic medicines [OR 5.88, 2.96-11.70, P < 0.001]) and lower socioeconomic status (prescription of ≥10 medications [OR: 1.43, 95% CI: 1.16-1.78], prescription of a long-acting benzodiazepine [OR: 1.84, CI: 1.14-2.98]). CONCLUSIONS: MCA use is associated with a significant incidence of PIMs particularly affecting those younger than 80 years and those living in deprived areas. Our findings indicate the need for a more aggressive multidisciplinary approach to the review of the medications prescribed to MCA users.
引用
- Counter D, Stewart D, MacLeod J, et al. Multicompartment compliance aids in the community: the prevalence of potentially inappropriate medications. Br J Clin Pharmacol. 2017. PMID: 28009450. doi:10.1111/bcp.13220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。